Lemaitre Vascular (LMAT) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
LeMaitre Vascular (LMAT) PT Raised to $29 at Stifel; Reiterates Buy
April 27, 2017 8:45 AM EDTStifel raised its price target on LeMaitre Vascular (NASDAQ: LMAT) to $29.00 (from $25.00) while maintaining a Buy rating. EPS of $0.16 grew 40%+ Y/Y. A lower than projected 1Q tax rate added $0.01-0.02 of EPS. But even excluding this benefit, the results still would have exceeded EPS... More



